Member Info for johnlaycock

I think this is going to be a very positive week for the company with the trading update on the 11th. If all the clues and hints on progress are true, then we could see a significant share rally back into the 20's.

Next week I suspect will be volatile in the run up to the presentation on Thursday but the overall trend will be up given the exciting progress and expected positive news flow. I reckon by the end of next week it will be safely in the 40's.

The CEX was clear that he needs funding for the FDA route so I dont think we will hear about a possible placing until after the FDA news/ US partners. This share can do a Angle (up 135% today) very easily once good news starts dropping, although granted the possible placing remains the elephant in the room.

I think all the hints and clues are there for a very encouraging trading update. Anything less, you would have to question the credibility and capability of the management.

Looks like another positive day ahead. People seem positive good news is due soon ahead of positive results on Jan 11th.

Fab news on many front including that the new CEX does what he says and sticks to promised timescales which is so important for investor and shareholder confidence.

I've just re-listened to the presentation again and in particular the timeframe for the multiple news flow items he mentioned - yes he did talk about before the end of the year on some but always then caveated that with or early next year / Jan (such as the new timeframe for Nice approval of the stroke test). So I wouldnt be surprised or worried if we didnt hear anything from him again in 2023 but certainly I would expect multiple positive updates in Jan. I personally think he will want all these to impact the shareprice before any possible raise, although I would assume this may come not long after news on the FDA partners etc.

MIKODX - you think a break out will happen in the run upto next year, but erm isnt that now given there are so few trading days before 2024??

I agree. The misrepresentation of what the CEX actually said yesterday is woeful.

They will want to get the price much higher than 4.5p pre placing. Promised good news in Dec and Jan should do the trick.

Best quote at the end...'I have really got the commercialisation traction going'

The contrast between Mr Cheek and David Budd is very stark - we now have a CEO with a plan. contacts, a commercialisation strategy etc etc. He was very tactful in describing the mess he inherited but in less than three months seems to have set a strong direction for the company to achieve rapid commercialisation success. There is now a real hope for both short and medium term positive news flow - I'm very much reassured we have a CEX who knows how to make this company a success and I am sure his approach will also give huge confidence to future investors too. Impressive.

But this is not a negative RNS!

How do you reach that view?!?

A good sign that RF have confidence in the new leadership.

Do you know that's his salary?

I still believe that the CEO would not have taken the job if he didn't think the company had a great future, albeit with speed bumps along the way!

This is old news. See the RNS on 28th Sept. The company has rehighlighted this today to try and cover up the disappointing NICE news re a further delay.

Whether the company is involved or not they can't announce anything until the contracts have been signed for the TRANSFORM programme which is not until next Spring.

I wonder if the company is involved in this ?

https://www.dailymail.co.uk/news/article-12764013/Health-leaders-approve-prostate-cancer-screening-trial.html